🇺🇸 tegafur-uracil in United States

149 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Diarrhoea — 38 reports (25.5%)
  2. Neutropenia — 18 reports (12.08%)
  3. Anaemia — 14 reports (9.4%)
  4. Vomiting — 14 reports (9.4%)
  5. Decreased Appetite — 11 reports (7.38%)
  6. Dehydration — 11 reports (7.38%)
  7. Pyrexia — 11 reports (7.38%)
  8. Stomatitis — 11 reports (7.38%)
  9. Thrombocytopenia — 11 reports (7.38%)
  10. Leukopenia — 10 reports (6.71%)

Source database →

Other Oncology approved in United States

Frequently asked questions

Is tegafur-uracil approved in United States?

tegafur-uracil does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for tegafur-uracil in United States?

Yokohama City University is the originator. The local marketing authorisation holder may differ — check the official source linked above.